Skip Navigation



JAC Advance Access published online on April 5, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl103
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
57/6/1172    most recent
dkl103v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fernandez-Hidalgo, N.
Right arrow Articles by Pahissa, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandez-Hidalgo, N.
Right arrow Articles by Pahissa, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Received February 19, 2006
Accepted March 6, 2006

Original article

Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study

Nuria Fernandez-Hidalgo 1 *, Benito Almirante 1, Raquel Calleja 2, Isabel Ruiz 1, Ana M. Planes 2, Dolors Rodriguez 1, Carles Pigrau 1, and Albert Pahissa 1

1 Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Medicine Department, Barcelona, Spain
2 Microbiology Department, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain

* To whom correspondence should be addressed.
Nuria Fernandez-Hidalgo, E-mail: nufernan{at}gmail.com


  Abstract

Background: Infection is one of the main problems associated with long-term central venous catheters. This study assesses the effectiveness of antibiotic-lock therapy (ALT) for treating catheter-related bacteraemia (CRB).

Methods: CRB was defined as quantitative blood culture counts through any catheter lumen 5-fold greater than concurrent peripheral blood culture, and qualitative blood culture positive for the same microorganism in all samples. Systemic treatment and ALT were started simultaneously using vancomycin (2000 mg/L) for Gram-positive organisms, and ciprofloxacin or amikacin (2000 mg/L) for Gram-negative bacilli. Heparin was added to ALT. Effectiveness was assessed by clinical and microbiological criteria. Cure was defined as negative blood cultures at both sites without catheter removal at 1 month after the completion of therapy.

Results: A total of 115 episodes of CRB in 98 patients were analysed. Catheters were used for chemotherapy (50 episodes), haemodialysis (37), total parenteral nutrition (24) and combined chemotherapy and nutrition (4). Median time from catheter placement to CRB onset was 105 days (IQ range 26-210). Aetiologies included Gram-positive organisms [56 coagulase-negative staphylococci (CoNS), 20 Staphylococcus aureus and 5 other organisms] in 81 episodes (70%), Gram-negative bacilli (11 Escherichia coli, 5 Pseudomonas aeruginosa and 10 other organisms) in 26 (23%) and polymicrobial in 8 (7%). A total of 94 episodes were cured (82%). There were 21 therapeutic failures: 9 S. aureus (1 related death), 9 CoNS, 1 P. aeruginosa, 1 Proteus vulgaris and 1 polymicrobial. Median catheter follow-up in therapeutic success was 168 days (range 7-2740).

Conclusions: ALT combined with systemic antibiotics seems to be effective for treating CRB, especially in Gram-negative and CoNS episodes. S. aureus CRB had an elevated rate of therapeutic failure.

Keywords: long-term central venous catheters; conservative treatment; outcome.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
J. Steczko, S. R. Ash, D. E. Nivens, L. Brewer, and R. K. Winger
Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens)
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1937 - 1945.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
Y. Qu, T. S. Istivan, A. J. Daley, D. A. Rouch, and M. A. Deighton
Comparison of various antimicrobial agents as catheter lock solutions: preference for ethanol in eradication of coagulase-negative staphylococcal biofilms
J. Med. Microbiol., April 1, 2009; 58(4): 442 - 450.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
A. M. Onder, J. Chandar, A. A. Billings, N. Simon, R. Diaz, D. Francoeur, C. Abitbol, and G. Zilleruelo
Comparison of Early versus Late Use of Antibiotic Locks in the Treatment of Catheter-Related Bacteremia
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1048 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. Allon
Current Management of Vascular Access
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 786 - 800.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. Fortun, F. Grill, P. Martin-Davila, J. Blazquez, M. Tato, J. Sanchez-Corral, L. Garcia-San Miguel, and S. Moreno
Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy
J. Antimicrob. Chemother., October 1, 2006; 58(4): 816 - 821.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.